Marpai Inc SEC Filings

Marpai, Inc. (MRAI) reported an insider equity transaction. A director acquired 50,000 shares of Class A common stock on 10/20/2025 at a reported price of $0.00, reflecting settlement of RSUs that were deemed fully vested on the issuance date.

Following the transaction, the reporting person beneficially owns 175,000 shares, held directly. The filing was made on Form 4 and indicates the transaction type as an acquisition.

Marpai, Inc. (MRAI) reported an insider transaction on a Form 4. The Chief Financial Officer acquired 275,000 shares of Class A common stock on 10/20/2025 at $0, issued as RSUs that were fully vested on the issuance date. Following this award, the officer beneficially owns 898,092 shares, held directly.

Marpai, Inc. (MRAI) director Robert Pons reported equity awards on a Form 4. On 10/20/2025, he acquired an aggregate 225,000 Class A common shares via RSUs at $0: 50,000 RSUs deemed fully vested on issuance; 75,000 RSUs vesting over nine months (25,000 at each three‑month interval); and 100,000 RSUs with 50,000 vested on issuance and 50,000 vesting upon the Company’s uplisting to Nasdaq.

Following these transactions, beneficial ownership was 309,200 shares as of 10/20/2025. These entries reflect stock-based compensation mechanics and vesting conditions rather than open-market purchases.

Marpai, Inc. (MRAI) reported an insider equity award. A director acquired 75,000 shares of Class A common stock on 10/20/2025 at a reported price of $0, reflecting settlement of restricted stock units.

Following this transaction, the reporting person beneficially owns 142,500 shares, held directly. The filing adds that the RSUs were deemed fully vested on the issuance date, indicating immediate vesting and delivery of shares.

Marpai, Inc. (MRAI): Schedule 13D/A Amendment No. 11 updates the ownership of Damien Lamendola and affiliated entities. Lamendola reports beneficial ownership of 7,501,528 shares, representing 40.51% of Marpai’s Class A common stock.

The filing attributes holdings to (i) 400,000 shares held directly by Lamendola, (ii) 6,109,893 shares held by HillCour Investment Fund, LLC, (iii) 931,674 shares held by WellEnterprises USA, LLC, and (iv) options for 62,500 shares at a $4.44 exercise price, of which 59,961 are vested. HillCour Investment Fund, LLC and WellEnterprises USA, LLC each report 7,041,567 shares beneficially owned (collective 38.03%).

The amendment notes share purchases in 2025: 86,805 (July 17), 371,470 (July 29), 896,903 (Sept 10), and 147,058 (Sept 30) pursuant to securities purchase agreements. Shares outstanding were 18,515,572 as of October 22, 2025.

Marpai, Inc. filed an amended Schedule 13G reporting that investment adviser Christopher M. Plahm has beneficial ownership of 572,359 shares of common stock, representing 3.10% of the class as of December 31, 2024. The filing shows shared voting power over these shares and no sole voting or dispositive power.

Holdings are attributed to advisory clients including Tall Pines Capital, LLC with 545,759 shares (2.96%) and Stonebridge Wealth Management, LLC with 26,600 shares (0.14%). The certification states the securities were not acquired to change or influence control.

Marpai, Inc. amended its charter to authorize 2,000,000 shares of blank-check preferred stock. This gives the board the ability to create one or more series of preferred shares with voting powers, preferences, and other rights set solely by the board.

The board approved the amendment on June 24, 2025; a majority of stockholders approved it at the annual meeting on August 27, 2025; and the amendment was filed in Delaware on October 17, 2025.

Marpai, Inc. (MRAI) — insider share sales reported. A reporting person filed a Form 4 showing open‑market sales of Common Shares on multiple dates: 10,000 shares at $1.43 on 08/13/2025; 20,000 at $1.40 on 08/15/2025; 20,000 at $1.40 on 08/18/2025; 20,000 at $1.40 on 08/19/2025; 10,000 at $1.42 on 08/20/2025; and 14,000 at $1.63 on 10/06/2025. Following the reported transactions, the filing lists 1,770,707 shares beneficially owned. The reporting person is indicated as a Director. Footnotes state the shares are held by IFCM MicroCap Fund LP, with Intelligent Fanatics Capital Management LLC as general partner; Mr. Cassel may be deemed a beneficial owner through shared voting and investment power and disclaims beneficial ownership except to the extent of his interests.

Marpai, Inc. (MRAI) filed an Form 8-K reporting a material event that attaches a Form of Securities Purchase Agreement as Exhibit 10.1 and an inline XBRL cover page file as Exhibit 104. The filing lists corporate communications categories related to securities and solicitation rules and identifies the security as Class A Common Stock traded on OTCQX. The form is signed by Damien Lamendola, Chief Executive Officer, with a signature date of October 6, 2025. The filing text supplied here does not include the agreement terms, financing amounts, counterparties, or other transaction economics, so material financial details are not available in this excerpt.